THE ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK (ORIEN) and HudsonAlpha Institute of Biotechnology announced a new collaboration to advance cancer research and care called The ORIEN Avatar Research Program. Under the agreement, HudsonAlpha will provide DNA sequences for 20,000 patient samples, tumor and non-tumor, by 2019 to identify the genetic disturbances and mutations of each patient’s...
The Cancer Letter has covered—and will continue to cover—all the ways in which the current administration is fundamentally reshaping cancer research in the U.S. But this week, The Cancer Letter and the podcast focused on a patient story.
